(TPR) Tapestry - Overview
Stock: Handbags, Footwear, Accessories, Apparel, Jewelry
| Risk 5d forecast | |
|---|---|
| Volatility | 37.9% |
| Relative Tail Risk | -12.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.70 |
| Alpha | 73.58 |
| Character TTM | |
|---|---|
| Beta | 1.281 |
| Beta Downside | 1.434 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.93% |
| CAGR/Max DD | 1.38 |
EPS (Earnings per Share)
Revenue
Description: TPR Tapestry February 11, 2026
Tapestry, Inc. (NYSE: TPR) is a multi-brand luxury-apparel and accessories conglomerate that markets its Coach, Kate Spade, and Stuart Weitzman lines through company-owned retail and outlet stores, e-commerce sites, and shop-in-shop concessions. Its product portfolio spans women’s and men’s handbags, small leather goods, footwear, apparel, jewelry, watches, eyewear, fragrance, and related accessories.
In the most recent fiscal quarter (Q2 FY 2024, ended 31 Dec 2023), Tapestry reported net revenue of **$2.12 billion**, a **6 % year-over-year increase** driven primarily by a **45 % digital-sales contribution** and a **10 % rise in comparable store sales** in North America. Gross margin expanded to **62 %**, reflecting higher-margin accessory mix and improved supply-chain efficiencies. The company’s exposure to the Greater China market is material-revenues from the region grew **8 % YoY**, aligning with a broader **5 % global luxury-goods CAGR** and a rebound in Chinese consumer confidence after the pandemic-related slowdown.
Key macro drivers for Tapestry include sustained US consumer-confidence levels (CCI ≈ 115 in Jan 2024), modest inflationary pressure on discretionary spending, and a gradual re-opening of Chinese luxury retail channels, which together suggest a **near-term upside potential** for premium-price positioning. However, any significant escalation in input-cost volatility or a sharp pull-back in Chinese tourism could materially affect earnings.
For a deeper, data-rich valuation framework, consider exploring Tapestry’s metrics on **ValueRay**, where you can model scenario-based outcomes with transparent assumptions.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 271.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 8.34 > 1.0 |
| NWC/Revenue: 12.51% < 20% (prev 109.4%; Δ -96.88% < -1%) |
| CFO/TA 0.19 > 3% & CFO 1.21b > Net Income 271.4m |
| Net Debt (3.48b) to EBITDA (583.8m): 5.96 < 3 |
| Current Ratio: 1.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (215.5m) vs 12m ago -8.65% < -2% |
| Gross Margin: 75.67% > 18% (prev 0.74%; Δ 7494 % > 0.5%) |
| Asset Turnover: 71.75% > 50% (prev 48.55%; Δ 23.20% > 0%) |
| Interest Coverage Ratio: 5.58 > 6 (EBITDA TTM 583.8m / Interest Expense TTM 67.5m) |
Altman Z'' -1.17
| A: 0.14 (Total Current Assets 2.62b - Total Current Liabilities 1.72b) / Total Assets 6.36b |
| B: -0.53 (Retained Earnings -3.36b / Total Assets 6.36b) |
| C: 0.04 (EBIT TTM 376.6m / Avg Total Assets 10.05b) |
| D: -0.60 (Book Value of Equity -3.59b / Total Liabilities 5.96b) |
| Altman-Z'' Score: -1.17 = CCC |
Beneish M -2.84
| DSRI: 1.04 (Receivables 610.7m/541.8m, Revenue 7.21b/6.67b) |
| GMI: 0.98 (GM 75.67% / 73.91%) |
| AQI: 1.45 (AQ_t 0.29 / AQ_t-1 0.20) |
| SGI: 1.08 (Revenue 7.21b / 6.67b) |
| TATA: -0.15 (NI 271.4m - CFO 1.21b) / TA 6.36b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of TPR shares?
Over the past week, the price has changed by +20.59%, over one month by +14.57%, over three months by +44.90% and over the past year by +96.90%.
Is TPR a buy, sell or hold?
- StrongBuy: 10
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the TPR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 142.2 | -7.2% |
| Analysts Target Price | 142.2 | -7.2% |
| ValueRay Target Price | 229.3 | 49.7% |
TPR Fundamental Data Overview February 07, 2026
P/E Forward = 25.5754
P/S = 3.8995
P/B = 52.5959
P/EG = 0.4401
Revenue TTM = 7.21b USD
EBIT TTM = 376.6m USD
EBITDA TTM = 583.8m USD
Long Term Debt = 2.38b USD (from longTermDebt, last quarter)
Short Term Debt = 565.4m USD (from shortTermDebt, last quarter)
Debt = 4.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.48b USD (from netDebt column, last quarter)
Enterprise Value = 32.78b USD (29.30b + Debt 4.20b - CCE 719.5m)
Interest Coverage Ratio = 5.58 (Ebit TTM 376.6m / Interest Expense TTM 67.5m)
EV/FCF = 30.35x (Enterprise Value 32.78b / FCF TTM 1.08b)
FCF Yield = 3.29% (FCF TTM 1.08b / Enterprise Value 32.78b)
FCF Margin = 14.99% (FCF TTM 1.08b / Revenue TTM 7.21b)
Net Margin = 3.77% (Net Income TTM 271.4m / Revenue TTM 7.21b)
Gross Margin = 75.67% ((Revenue TTM 7.21b - Cost of Revenue TTM 1.75b) / Revenue TTM)
Gross Margin QoQ = 76.29% (prev 76.32%)
Tobins Q-Ratio = 5.15 (Enterprise Value 32.78b / Total Assets 6.36b)
Interest Expense / Debt = 0.30% (Interest Expense 12.8m / Debt 4.20b)
Taxrate = 13.77% (43.9m / 318.7m)
NOPAT = 324.7m (EBIT 376.6m * (1 - 13.77%))
Current Ratio = 1.52 (Total Current Assets 2.62b / Total Current Liabilities 1.72b)
Debt / Equity = 10.51 (Debt 4.20b / totalStockholderEquity, last quarter 399.5m)
Debt / EBITDA = 5.96 (Net Debt 3.48b / EBITDA 583.8m)
Debt / FCF = 3.22 (Net Debt 3.48b / FCF TTM 1.08b)
Total Stockholder Equity = 1.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.70% (Net Income 271.4m / Total Assets 6.36b)
RoE = 26.56% (Net Income TTM 271.4m / Total Stockholder Equity 1.02b)
RoCE = 11.07% (EBIT 376.6m / Capital Employed (Equity 1.02b + L.T.Debt 2.38b))
RoIC = 8.96% (NOPAT 324.7m / Invested Capital 3.62b)
WACC = 9.34% (E(29.30b)/V(33.50b) * Re(10.64%) + D(4.20b)/V(33.50b) * Rd(0.30%) * (1-Tc(0.14)))
Discount Rate = 10.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.56%
[DCF Debug] Terminal Value 73.39% ; FCFF base≈1.12b ; Y1≈1.13b ; Y5≈1.20b
Fair Price DCF = 65.35 (EV 16.71b - Net Debt 3.48b = Equity 13.23b / Shares 202.5m; r=9.34% [WACC]; 5y FCF grow -0.21% → 2.90% )
EPS Correlation: 63.20 | EPS CAGR: 55.81% | SUE: 4.0 | # QB: 2
Revenue Correlation: 1.73 | Revenue CAGR: -5.90% | SUE: 1.81 | # QB: 5
EPS next Quarter (2026-03-31): EPS=1.27 | Chg30d=+0.270 | Revisions Net=+8 | Analysts=6
EPS current Year (2026-06-30): EPS=5.97 | Chg30d=+0.362 | Revisions Net=+12 | Growth EPS=+17.0% | Growth Revenue=+7.4%
EPS next Year (2027-06-30): EPS=6.60 | Chg30d=+0.392 | Revisions Net=+10 | Growth EPS=+10.6% | Growth Revenue=+4.8%